Does ENTRECTINIB Cause Hepatic function abnormal? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hepatic function abnormal have been filed in association with ENTRECTINIB (Rozlytrek). This represents 1.1% of all adverse event reports for ENTRECTINIB.
16
Reports of Hepatic function abnormal with ENTRECTINIB
1.1%
of all ENTRECTINIB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hepatic function abnormal From ENTRECTINIB?
Of the 16 reports, 5 (31.3%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENTRECTINIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does ENTRECTINIB Cause?
Dizziness (143)
Off label use (137)
Death (126)
Disease progression (105)
Taste disorder (68)
No adverse event (65)
Constipation (60)
Fatigue (60)
Drug ineffective (58)
Blood creatinine increased (57)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ENTRECTINIB Alternatives Have Lower Hepatic function abnormal Risk?
ENTRECTINIB vs ENZALUTAMIDE
ENTRECTINIB vs EPCORITAMAB
ENTRECTINIB vs EPCORITAMAB-BYSP
ENTRECTINIB vs EPERISONE
ENTRECTINIB vs EPHEDRINE